BD Infusate Companion

Your guide to infusates.

Free · Designed for iPad

The BD Infusate Consideration Companion may help you identify medications that may or may not be given in peripheral veins to help reduce risks and complications. When selecting a vascular access device, are you considering both the infusates and the potential infusion complications? Thrombosis, thrombophlebitis, phlebitis, necrosis following extravasation of a vesicant drug, and pain/redness during infusion may be potential complications. The BD Infusate Consideration Companion (ICC) may help you identify medications that are non-peripherally compatible. Consideration of peripheral vein preservation and minimizing harm should be a factor in device selection. Selecting the appropriate device for a patient is a critical part of a clinician’s job. These materials are being provided for your information only and are not a substitute for clinical judgment.

  • 5.0
    out of 5
    5 Ratings

minor bug fix

The developer, Becton, Dickinson, and Company, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .

  • Data Not Collected

    The developer does not collect any data from this app.

    Privacy practices may vary, for example, based on the features you use or your age. Learn More

    The developer has not yet indicated which accessibility features this app supports. Learn More

    • Seller
      • Becton, Dickinson, and Company
    • Size
      • 7.6 MB
    • Category
      • Medical
    • Compatibility
      Requires iOS 14.0 or later.
      • iPhone
        Requires iOS 14.0 or later.
      • iPad
        Requires iPadOS 14.0 or later.
      • iPod touch
        Requires iOS 14.0 or later.
      • Mac
        Requires macOS 11.0 or later and a Mac with Apple M1 chip or later.
      • Apple Vision
        Requires visionOS 1.0 or later.
    • Languages
      • English
    • Age Rating
      4+
    • Copyright
      • © 2022 BD. All rights reserved. Becton, Dickinson and Company.